Indian MedTech companies often ask which global markets they can enter with Indian CDSCO approval alone. Our comprehensive review reveals that while it's a powerful entry enabler for lower-risk devices in Asia and Africa, it’s insufficient for long-term global scale or higher-risk devices. Strategic expansion requires understanding where Indian approval serves as a steppingstone and where mandatory reference-market approvals are indispensable, guiding intelligent sequencing and capital-efficient growth.

Japan’s medical device market is expanding rapidly, driven by an aging population and rising life expectancy, yet domestic manufacturing alone is struggling to keep pace due to cost pressures and capacity constraints. As a result, many Japanese MedTech companies are increasingly exploring global contract design and manufacturing partnerships, with India emerging as a strategic and trusted hub supported by strong India–Japan ties and initiatives such as JETRO.

Corporate Social emerged from the realisation that follower count is a weak driver of meaningful engagement beyond a basic threshold, as LinkedIn primarily rewards recency and early reactions rather than depth or expertise. While LinkedIn remains useful as a visibility and validation layer, building durable professional credibility requires a dedicated space for long-form, owned, and compounding insight, something Corporate Social is designed to provide.